Literature DB >> 19595695

High-fat feeding in cardiomyocyte-restricted PPARdelta knockout mice leads to cardiac overexpression of lipid metabolic genes but fails to rescue cardiac phenotypes.

Yuquan Li1, Lihong Cheng, Qianhong Qin, Jian Liu, Woo-kuen Lo, Lowrence A Brako, Qinglin Yang.   

Abstract

Peroxisome proliferator-activated receptor delta (PPARdelta) is an essential determinant of basal myocardial fatty acid oxidation (FAO) and bioenergetics. We wished to determine whether increased lipid loading affects the PPARdelta deficient heart in transcriptional regulation of FAO and in the development of cardiac pathology. Cardiomyocyte-restricted PPARdelta knockout (CR-PPARdelta(-/-)) and control (alpha-MyHC-Cre) mice were subjected to 48 h of fasting and to a long-term maintenance on a (28 weeks) high-fat diet (HFD). The expression of key FAO proteins in heart was examined. Serum lipid profiles, cardiac pathology, and changes of various transduction signaling pathways were also examined. Mice subjected to fasting exhibited upregulated transcript expression of FAO genes in the CR-PPARdelta(-/-) hearts. Moreover, long-term HFD in CR-PPARdelta(-/-) mice induced a strikingly greater transcriptional response. After HFD, genes encoding key FAO enzymes were expressed remarkably more in CR-PPARdelta(-/-) hearts than in those of control mice. Despite the marked rise of FAO gene expression, corresponding protein expression remained low in the CR-PPARdelta(-/-) heart, accompanied by abnormalities in sarcomere structures and mitochondria that were similar to those of CR-PPARdelta(-/-) hearts with regular chow feeding. The CR-PPARdelta(-/-) mice displayed increased expression of PPARgamma co-activator-1alpha (PGC-1alpha) and PPARalpha in the heart with deactivated Akt and p42/44 MAPK signaling in response to HFD. We conclude that PPARdelta is an essential determinant of myocardial FAO. Increased lipid intake activates cardiac expression of FAO genes via PPARalpha/PGC-1alpha pathway, albeit it is not sufficient to improve cardiac pathology due to PPARdelta deficiency.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19595695      PMCID: PMC2766590          DOI: 10.1016/j.yjmcc.2009.07.001

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  28 in total

1.  Endogenous nitric oxide mechanisms mediate the stretch dependence of Ca2+ release in cardiomyocytes.

Authors:  M G Petroff; S H Kim; S Pepe; C Dessy; E Marbán; J L Balligand; S J Sollott
Journal:  Nat Cell Biol       Date:  2001-10       Impact factor: 28.824

Review 2.  The physiology of cellular liporegulation.

Authors:  Roger H Unger
Journal:  Annu Rev Physiol       Date:  2002-05-01       Impact factor: 19.318

3.  Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer.

Authors:  Yaacov Barak; Debbie Liao; Weimin He; Estelita S Ong; Michael C Nelson; Jerrold M Olefsky; Richard Boland; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

4.  Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity.

Authors:  Yong-Xu Wang; Chih-Hao Lee; Sambath Tiep; Ruth T Yu; Jungyeob Ham; Heonjoong Kang; Ronald M Evans
Journal:  Cell       Date:  2003-04-18       Impact factor: 41.582

5.  Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis.

Authors:  J J Lehman; P M Barger; A Kovacs; J E Saffitz; D M Medeiros; D P Kelly
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

6.  Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism.

Authors:  Andries J Gilde; Karin A J M van der Lee; Peter H M Willemsen; Giulia Chinetti; Feike R van der Leij; Ger J van der Vusse; Bart Staels; Marc van Bilsen
Journal:  Circ Res       Date:  2003-02-06       Impact factor: 17.367

7.  Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR.

Authors:  Hiroaki Daitoku; Kazuyuki Yamagata; Hitomi Matsuzaki; Mitsutoki Hatta; Akiyoshi Fukamizu
Journal:  Diabetes       Date:  2003-03       Impact factor: 9.461

8.  Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart.

Authors:  Martin E Young; Patrick H Guthrie; Peter Razeghi; Brendan Leighton; Shahrzad Abbasi; Sarita Patil; Keith A Youker; Heinrich Taegtmeyer
Journal:  Diabetes       Date:  2002-08       Impact factor: 9.461

9.  Conjugated linoleic acid enhances plasma adiponectin level and alleviates hyperinsulinemia and hypertension in Zucker diabetic fatty (fa/fa) rats.

Authors:  Koji Nagao; Nao Inoue; Yu-Ming Wang; Teruyoshi Yanagita
Journal:  Biochem Biophys Res Commun       Date:  2003-10-17       Impact factor: 3.575

10.  Peroxisome proliferator-activated receptor delta activates fatty acid oxidation in cultured neonatal and adult cardiomyocytes.

Authors:  Lihong Cheng; Guoliang Ding; Qianhong Qin; Yan Xiao; David Woods; Yuqing E Chen; Qinglin Yang
Journal:  Biochem Biophys Res Commun       Date:  2004-01-09       Impact factor: 3.322

View more
  11 in total

Review 1.  The endocannabinoid system in cardiovascular function: novel insights and clinical implications.

Authors:  Salvador Sierra; Natasha Luquin; Judith Navarro-Otano
Journal:  Clin Auton Res       Date:  2017-12-08       Impact factor: 4.435

2.  Peroxisome proliferator-activated receptor β/δ activation in adult hearts facilitates mitochondrial function and cardiac performance under pressure-overload condition.

Authors:  Jian Liu; Peiyong Wang; Jinwen Luo; Yao Huang; Lan He; Huan Yang; Qingbao Li; Sijie Wu; Olga Zhelyabovska; Qinglin Yang
Journal:  Hypertension       Date:  2011-01-10       Impact factor: 10.190

3.  Conditional PPARγ knockout from cardiomyocytes of adult mice impairs myocardial fatty acid utilization and cardiac function.

Authors:  Jinwen Luo; Sijie Wu; Jian Liu; Yuquan Li; Huan Yang; Teayoun Kim; Olga Zhelyabovska; Guoliang Ding; Yiqun Zhou; Yifeng Yang; Qinglin Yang
Journal:  Am J Transl Res       Date:  2010-10-01       Impact factor: 4.060

4.  Dual peroxisome-proliferator-activated-receptor-α/γ activation inhibits SIRT1-PGC1α axis and causes cardiac dysfunction.

Authors:  Charikleia Kalliora; Ioannis D Kyriazis; Shin-Ichi Oka; Melissa J Lieu; Yujia Yue; Estela Area-Gomez; Christine J Pol; Ying Tian; Wataru Mizushima; Adave Chin; Diego Scerbo; P Christian Schulze; Mete Civelek; Junichi Sadoshima; Muniswamy Madesh; Ira J Goldberg; Konstantinos Drosatos
Journal:  JCI Insight       Date:  2019-08-08

Review 5.  Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease.

Authors:  Salman Azhar
Journal:  Future Cardiol       Date:  2010-09

6.  Peroxisome proliferator-activated receptor {delta} is an essential transcriptional regulator for mitochondrial protection and biogenesis in adult heart.

Authors:  Peiyong Wang; Jian Liu; Yuquan Li; Sijie Wu; Jinwen Luo; Huan Yang; Ramasamy Subbiah; John Chatham; Olga Zhelyabovska; Qinglin Yang
Journal:  Circ Res       Date:  2010-01-14       Impact factor: 17.367

7.  Cardiomyocyte-Restricted Deletion of PPARβ/δ in PPARα-Null Mice Causes Impaired Mitochondrial Biogenesis and Defense, but No Further Depression of Myocardial Fatty Acid Oxidation.

Authors:  Jian Liu; Peiyong Wang; Lan He; Yuquan Li; Jinwen Luo; Lihong Cheng; Qianhong Qin; Lawrence A Brako; Woo-Kuen Lo; William Lewis; Qinglin Yang
Journal:  PPAR Res       Date:  2011-09-05       Impact factor: 4.964

Review 8.  The Glitazars Paradox: Cardiotoxicity of the Metabolically Beneficial Dual PPARα and PPARγ Activation.

Authors:  Charikleia Kalliora; Konstantinos Drosatos
Journal:  J Cardiovasc Pharmacol       Date:  2020-11       Impact factor: 3.271

9.  Neuron-specific deletion of peroxisome proliferator-activated receptor delta (PPARδ) in mice leads to increased susceptibility to diet-induced obesity.

Authors:  Heidi E Kocalis; Maxine K Turney; Richard L Printz; Gloria N Laryea; Louis J Muglia; Sean S Davies; Gregg D Stanwood; Owen P McGuinness; Kevin D Niswender
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

10.  Docosahexaenoic acid supplementation does not improve Western diet-induced cardiomyopathy in rats.

Authors:  Kimberly M Jeckel; D N Rao Veeramachaneni; Adam J Chicco; Phillip L Chapman; Christopher M Mulligan; Jennifer R Hegarty; Michael J Pagliassotti; Lindsay A Ferguson; Gerrit J Bouma; Melinda A Frye
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.